Which medication class is considered a controller medication for pediatric asthma?

• A. ICS (beclomethasone, budesonide, futicasone)
• B. SABA
• C. Anticholinergic inhaler
• D. Short-acting PDE inhibitors

Answer: (A)

Controlling pediatric asthma focuses on reducing the chronic inflammation of the airways so symptoms are minimized and flare-ups are prevented. Inhaled corticosteroids are the standard long-term controller because they directly dampen that inflammation, leading to fewer symptoms, better lung function, and fewer exacerbations with regular, daily use. They are used at low to medium doses depending on severity and can be prescribed with a spacer to improve delivery; common inhaled steroids include beclomethasone, budesonide, and fluticasone.

Quick-relief medications, like short-acting beta-agonists, provide rapid relief of acute symptoms but do not address the underlying inflammation, so they’re not controllers. Anticholinergic inhalers aren’t used as routine controllers in children; they’re more for acute management or specific situations rather than long-term control. Short-acting PDE inhibitors, such as theophylline, are older options with more side effects and are not preferred as chronic controller therapy.